RBC Europe’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-1,000
| Closed | -$15.6K | – | 1228 |
|
|
2020
Q4 | $15.6K | Hold |
1,000
| – | – | ﹤0.01% | 779 |
|
|
2020
Q3 | $9.45K | Hold |
1,000
| – | – | ﹤0.01% | 809 |
|
|
2020
Q2 | $8.96K | Hold |
1,000
| – | – | ﹤0.01% | 790 |
|
|
2020
Q1 | $6.37K | Hold |
1,000
| – | – | ﹤0.01% | 792 |
|
|
2019
Q4 | $8.37K | Hold |
1,000
| – | – | ﹤0.01% | 831 |
|
|
2019
Q3 | $9.05K | Hold |
1,000
| – | – | ﹤0.01% | 805 |
|
|
2019
Q2 | $10.8K | Hold |
1,000
| – | – | ﹤0.01% | 791 |
|
|
2019
Q1 | $9.54K | Hold |
1,000
| – | – | ﹤0.01% | 830 |
|
|
2018
Q4 | $11.5K | Hold |
1,000
| – | – | ﹤0.01% | 758 |
|
|
2018
Q3 | $17K | Hold |
1,000
| – | – | ﹤0.01% | 717 |
|
|
2018
Q2 | $14.2K | Hold |
1,000
| – | – | ﹤0.01% | 760 |
|
|
2018
Q1 | $19K | Hold |
1,000
| – | – | ﹤0.01% | 684 |
|
|
2017
Q4 | $16.4K | Hold |
1,000
| – | – | ﹤0.01% | 735 |
|
|
2017
Q3 | $15K | Buy |
+1,000
| New | +$15K | ﹤0.01% | 751 |
|